Data on margin financing for several new share offerings is available.
As of June 1, Dajin Heavy Industry (01081), Longbio-B (01779), and Lung Fung Group (02290) are in the process of their public offerings.
According to information from securities firms including Futu Securities and Phillip Securities, Dajin Heavy Industry has seen margin financing of HK$17.459 billion, representing an oversubscription of over 29.23 times.
Longbio-B has attracted margin financing of HK$164.953 billion, indicating an oversubscription exceeding 1,208.84 times.
Lung Fung Group has recorded margin financing of HK$6.306 billion, which translates to an oversubscription of over 78.07 times.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.